EPI-7386, Xtandi - 40 mg soft capsules
EPI-7386-CS-010
Phase 2 small_molecule active
Quick answer
EPI-7386, Xtandi - 40 mg soft capsules for Metastatic castration-resistant prostate cancer is a Phase 2 program (small_molecule) at Pharma Mar S.A. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pharma Mar S.A.
- Indication
- Metastatic castration-resistant prostate cancer
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active